Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

626 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland.
Bachofner J, Valli PV, Bergamin I, Kröger A, Künzler P, Baserga A, Braun DL, Seifert B, Moncsek A, Fehr J, Semela D, Magenta L, Müllhaupt B, Terziroli Beretta-Piccoli B, Mertens J, The Swiss Hepatitis C Cohort Study. Bachofner J, et al. Among authors: fehr j. Swiss Med Wkly. 2018 Jan 18;148:w14560. doi: 10.4414/smw.2018.14560. eCollection 2018. Swiss Med Wkly. 2018. PMID: 29376557 Free article.
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.
Metzner KJ, Scherrer AU, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Battegay M, Vernazza PL, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard HF; Swiss HIV Cohort Study. Metzner KJ, et al. J Infect Dis. 2013 Oct 1;208(7):1102-12. doi: 10.1093/infdis/jit310. Epub 2013 Jul 11. J Infect Dis. 2013. PMID: 23847055 Free article.
[Treatment of hepatitis C - an imminent revolution].
Schärer V, Bruggmann P, Müllhaupt B, Fehr J. Schärer V, et al. Among authors: fehr j. Praxis (Bern 1994). 2014 Sep 17;103(19):1123-31. doi: 10.1024/1661-8157/a001782. Praxis (Bern 1994). 2014. PMID: 25228574 German.
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Braun DL, Rauch A, Aouri M, Durisch N, Eberhard N, Anagnostopoulos A, Ledergerber B, Müllhaupt B, Metzner KJ, Decosterd L, Böni J, Weber R, Fehr J; Swiss HIV Cohort Study. Braun DL, et al. Among authors: fehr j. PLoS One. 2015 Jul 15;10(7):e0133028. doi: 10.1371/journal.pone.0133028. eCollection 2015. PLoS One. 2015. PMID: 26176696 Free PMC article. Clinical Trial.
Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.
Bachofner JA, Valli PV, Kröger A, Bergamin I, Künzler P, Baserga A, Braun D, Seifert B, Moncsek A, Fehr J, Semela D, Magenta L, Müllhaupt B, Terziroli Beretta-Piccoli B, Mertens JC. Bachofner JA, et al. Among authors: fehr j. Liver Int. 2017 Mar;37(3):369-376. doi: 10.1111/liv.13256. Epub 2016 Nov 3. Liver Int. 2017. PMID: 27678216
Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.
Bruggmann P, Blach S, Deltenre P, Fehr J, Kouyos R, Lavanchy D, Müllhaupt B, Rauch A, Razavi H, Schmid P, Semela D, Stoeckle M, Negro F. Bruggmann P, et al. Among authors: fehr j. Swiss Med Wkly. 2017 Nov 8;147:w14543. doi: 10.4414/smw.2017.14543. eCollection 2017. Swiss Med Wkly. 2017. PMID: 29120012 Free article.
626 results